Skip to main content
Top
Published in: European Journal of Epidemiology 1/2012

01-01-2012 | CANCER

Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976–2005

Authors: Shan Gao, Wan-Shui Yang, Freddie Bray, Puthiery Va, Wei Zhang, Jing Gao, Yong-Bing Xiang

Published in: European Journal of Epidemiology | Issue 1/2012

Login to get access

Abstract

In China, hepatocellular carcinoma (HCC) incidence rates in several registry catchment populations are amongst the highest worldwide. The incidence rates in urban Shanghai were analyzed between 1976 and 2005 to describe and interpret the time trends. Age-specific and age-standardized rates were calculated and graphically presented. An age-period-cohort model was fitted to assess the effects of age at diagnosis, calendar period, and birth cohort on the changing HCC incidence rates. In total, 35,241 and 13,931 men and women were diagnosed with HCC during 1976–2005 in urban Shanghai. The age-standardized incidence rates in urban Shanghai were 33.9 per 105 among men and 11.4 per 105 among women in 1976–1980, but decreased in both sexes to 25.8 per 105 and 8.5 per 105, respectively by 2001–2005. Accelerating rates in birth cohorts born in the early-1930s and decelerating rates circa 1945 were observed in both sexes, with further accelerations noted in the late-1950s (in women) and early-1960s (in men). Given the parameterization, increases in risk of HCC were seen in successive male and female generations between 1900 and 1935, followed by a further increase among successive cohorts born around 1960, with a reduction in risk in the most recent generations. The incidence rates of HCC in urban Shanghai from 1976 to 2005 have declined in both sexes, with the complex but similar patterns observed in successive generations suggestive of a shared changing prevalence in risk factors in men and women, with a role possibly for HBV interventions reducing risk of HCC in cohorts born after 1960.
Literature
2.
go back to reference Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P. Cancer incidence in five continents, vol. IX. Lyon: IARC Scientific Publications; 2007. vol. 160, pp. 1–897. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P. Cancer incidence in five continents, vol. IX. Lyon: IARC Scientific Publications; 2007. vol. 160, pp. 1–897.
3.
go back to reference International Agency for Research on Cancer. Cancer incidence in five continents. 2010 [Internet] [cited 2010 December 3]. Available from URL: http://ci5.iarc.fr/. International Agency for Research on Cancer. Cancer incidence in five continents. 2010 [Internet] [cited 2010 December 3]. Available from URL: http://​ci5.​iarc.​fr/​.
4.
go back to reference The Shanghai Cancer Registry. The incidence rates of malignant tumors in urban Shanghai, 2007. Tumor (Shanghai) 2010;30:726. The Shanghai Cancer Registry. The incidence rates of malignant tumors in urban Shanghai, 2007. Tumor (Shanghai) 2010;30:726.
5.
go back to reference Clayton D, Schifflers E. Models for temporal variation in cancer rates I: age-period and age-cohort models. Stat Med. 1987;6(4):449–67.PubMedCrossRef Clayton D, Schifflers E. Models for temporal variation in cancer rates I: age-period and age-cohort models. Stat Med. 1987;6(4):449–67.PubMedCrossRef
6.
go back to reference Clayton D, Schifflers E. Models for temporal variation in cancer rates II: age- period- cohort models. Stat Med. 1987;6(4):469–81.PubMedCrossRef Clayton D, Schifflers E. Models for temporal variation in cancer rates II: age- period- cohort models. Stat Med. 1987;6(4):469–81.PubMedCrossRef
7.
go back to reference Lee LT, Huang HY, Huang KC, Chen CY, Lee WC. Age-period-cohort analysis of hepatocellular carcinoma mortality in Taiwan, 1976–2005. Ann Epidemiol. 2009;19(5):323–8.PubMedCrossRef Lee LT, Huang HY, Huang KC, Chen CY, Lee WC. Age-period-cohort analysis of hepatocellular carcinoma mortality in Taiwan, 1976–2005. Ann Epidemiol. 2009;19(5):323–8.PubMedCrossRef
8.
go back to reference Dal Maso L, Lise M, Zambon P, Crocetti E, Serraino D, Ricceri F, Vercelli M, De Lisi V, Tagliabue G, Federico M, Falcini F, Cassetti T, et al. Incidence of primary liver cancer in Italy between 1988 and 2002: an age-period-cohort analysis. Eur J Cancer. 2008;44(2):285–92.PubMedCrossRef Dal Maso L, Lise M, Zambon P, Crocetti E, Serraino D, Ricceri F, Vercelli M, De Lisi V, Tagliabue G, Federico M, Falcini F, Cassetti T, et al. Incidence of primary liver cancer in Italy between 1988 and 2002: an age-period-cohort analysis. Eur J Cancer. 2008;44(2):285–92.PubMedCrossRef
9.
go back to reference Gao YT, Lu W. Cancer incidence, mortality and survival rates in urban Shanghai (1973-2000). Shanghai: Second Military Medical University Press; 2007. p. 443. Gao YT, Lu W. Cancer incidence, mortality and survival rates in urban Shanghai (1973-2000). Shanghai: Second Military Medical University Press; 2007. p. 443.
10.
11.
go back to reference Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, vol. VIII. Lyon, France: IARC Science Publication; 2002. vol. 155, pp. 1–781. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, vol. VIII. Lyon, France: IARC Science Publication; 2002. vol. 155, pp. 1–781.
12.
go back to reference Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, Edwards BK. Partitioning linear trends in age-adjusted rates. Cancer Cause Control. 2000;11(1):31–5.CrossRef Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, Edwards BK. Partitioning linear trends in age-adjusted rates. Cancer Cause Control. 2000;11(1):31–5.CrossRef
13.
go back to reference Viel JF, Fournier E, Danzon A. Age-period-cohort modeling of non-Hodgkin’s lymphoma incidence in a French region: a period effect compatible with an environmental exposure. Environ Health. 2010;9:47.PubMedCrossRef Viel JF, Fournier E, Danzon A. Age-period-cohort modeling of non-Hodgkin’s lymphoma incidence in a French region: a period effect compatible with an environmental exposure. Environ Health. 2010;9:47.PubMedCrossRef
14.
go back to reference Zong ZH, Shen QJ, Chen JG, Li WG, Yao HY. Application of Bayesian graphical modeling to analysis of the incidence data of primary liver cancer in Qidong county. Chin J Health Stat. 2005;22:13–5. Zong ZH, Shen QJ, Chen JG, Li WG, Yao HY. Application of Bayesian graphical modeling to analysis of the incidence data of primary liver cancer in Qidong county. Chin J Health Stat. 2005;22:13–5.
15.
go back to reference Shen QJ, Zhang XF, Chen JG, Li WG, Yao HY. An age-period-cohort modeling study on primary liver cancer incidence rate in Qidong. Clin J Epidemiol. 2004;25:902–4. Shen QJ, Zhang XF, Chen JG, Li WG, Yao HY. An age-period-cohort modeling study on primary liver cancer incidence rate in Qidong. Clin J Epidemiol. 2004;25:902–4.
16.
go back to reference R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2010. ISBN 3-900051-07-0. [Internet] 2010 [cited 2010 December 3]. Available from: http://www.R-project.org. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2010. ISBN 3-900051-07-0. [Internet] 2010 [cited 2010 December 3]. Available from: http://​www.​R-project.​org.
18.
go back to reference Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett. 2009;286(1):9–14. Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett. 2009;286(1):9–14.
19.
go back to reference Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes. Hepatology. 2008;47(6):1856–62.PubMedCrossRef Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes. Hepatology. 2008;47(6):1856–62.PubMedCrossRef
20.
go back to reference Lu F, Zhuan H. Prevention of hepatitis B in China: achievements and challenges. Chin Med J. 2009;122:2925–7.PubMed Lu F, Zhuan H. Prevention of hepatitis B in China: achievements and challenges. Chin Med J. 2009;122:2925–7.PubMed
21.
go back to reference Barazani Y, Hiatt JR, Tong MJ, Busuttil RW. Chronic viral hepatitis and hepatocellular carcinoma. World J Surg. 2007;31(6):1243–8.PubMedCrossRef Barazani Y, Hiatt JR, Tong MJ, Busuttil RW. Chronic viral hepatitis and hepatocellular carcinoma. World J Surg. 2007;31(6):1243–8.PubMedCrossRef
22.
go back to reference Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut. 1996;38(Suppl 2):S39–42.PubMedCrossRef Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut. 1996;38(Suppl 2):S39–42.PubMedCrossRef
23.
go back to reference Li YT, Wu HY, Zhang AX, Shen WJ, Yuan GJ. Epidemiological effect observed after hepatitis B immunization of newborns in different regions in Shanghai. Shanghai J Prev Med. 2000;12:410–1. Li YT, Wu HY, Zhang AX, Shen WJ, Yuan GJ. Epidemiological effect observed after hepatitis B immunization of newborns in different regions in Shanghai. Shanghai J Prev Med. 2000;12:410–1.
24.
go back to reference Lu W, Zheng Y. Prevalence and prevention measure of cancer in Shanghai. China Cancer. 2009;18:90–1. Lu W, Zheng Y. Prevalence and prevention measure of cancer in Shanghai. China Cancer. 2009;18:90–1.
25.
go back to reference Zhang AX, Li YT, Xu Q, et al. Review and measures of hepatitis B immunization in Shanghai. Shanghai J Prev Med. 2000;12:408–10. Zhang AX, Li YT, Xu Q, et al. Review and measures of hepatitis B immunization in Shanghai. Shanghai J Prev Med. 2000;12:408–10.
26.
go back to reference Castells L, Vargas V, Gonzalez A, Esteban J, Esteban R, Guardia J. Long interval between HCV infection and the development of hepatocellular carcinoma. Liver. 1995;15(3):159–63.PubMed Castells L, Vargas V, Gonzalez A, Esteban J, Esteban R, Guardia J. Long interval between HCV infection and the development of hepatocellular carcinoma. Liver. 1995;15(3):159–63.PubMed
27.
go back to reference Zhao SJ, Xu ZY, Lu Y. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. Int J Epidemiol. 2000;29(4):744–52.PubMedCrossRef Zhao SJ, Xu ZY, Lu Y. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. Int J Epidemiol. 2000;29(4):744–52.PubMedCrossRef
28.
go back to reference Lu W, Li DL, Zheng Y. Conception of cancer prevention and control strategy in Shanghai. China Cancer. 2001;10:187–8. Lu W, Li DL, Zheng Y. Conception of cancer prevention and control strategy in Shanghai. China Cancer. 2001;10:187–8.
29.
go back to reference Wang J, Liu XM. Assessment of dietary aflatoxins exposure in Chinese residents. Chin J Food Hygiene. 2007;19(3):238–40. Wang J, Liu XM. Assessment of dietary aflatoxins exposure in Chinese residents. Chin J Food Hygiene. 2007;19(3):238–40.
30.
go back to reference Yeh FS, Shen KN. Epidemiology and early diagnosis of primary liver cancer in China. Adv Cancer Res. 1986;47:297–329.CrossRef Yeh FS, Shen KN. Epidemiology and early diagnosis of primary liver cancer in China. Adv Cancer Res. 1986;47:297–329.CrossRef
31.
go back to reference China Cancer Prevention and Treatment Office. The diagnostic standard on primary liver cancer. Chin J Hepato Surg. 1998;4:103. China Cancer Prevention and Treatment Office. The diagnostic standard on primary liver cancer. Chin J Hepato Surg. 1998;4:103.
32.
go back to reference Keyes KM, Utz RL, Robinson W, Li GH. What is a cohort effect? Comparison of three statistical methods for modeling cohort effects in obesity prevalence in the United States, 1971–2006. Soc Sci Med. 2010;70(7):1100–8.PubMedCrossRef Keyes KM, Utz RL, Robinson W, Li GH. What is a cohort effect? Comparison of three statistical methods for modeling cohort effects in obesity prevalence in the United States, 1971–2006. Soc Sci Med. 2010;70(7):1100–8.PubMedCrossRef
33.
go back to reference Reimers LL, Anderson WF, Rosenberg PS, Henson DE, Castle PE. Etiological heterogeneity for cervical carcinoma by histopathological type, using comparative age-period-cohort (APC) models. Cancer Epidemiol Biomarkers Prev. 2009;18(3):792–800.PubMedCrossRef Reimers LL, Anderson WF, Rosenberg PS, Henson DE, Castle PE. Etiological heterogeneity for cervical carcinoma by histopathological type, using comparative age-period-cohort (APC) models. Cancer Epidemiol Biomarkers Prev. 2009;18(3):792–800.PubMedCrossRef
34.
go back to reference Jia WH, Huang QH, Liao J, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983–2002) in Sihui and Cangwu counties in southern China. BMC Cancer. 2006;6:178.PubMedCrossRef Jia WH, Huang QH, Liao J, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983–2002) in Sihui and Cangwu counties in southern China. BMC Cancer. 2006;6:178.PubMedCrossRef
35.
go back to reference Gao S, Yang WS, Gao J, Wang J, Xiang YB. A Meta-analysis of cohort studies on the association between diabetes and the risk of primary liver cancer. Chin J Prev Med. 2010;44(8):711–6. Gao S, Yang WS, Gao J, Wang J, Xiang YB. A Meta-analysis of cohort studies on the association between diabetes and the risk of primary liver cancer. Chin J Prev Med. 2010;44(8):711–6.
36.
go back to reference Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006;43(6):1295–302.PubMedCrossRef Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006;43(6):1295–302.PubMedCrossRef
37.
go back to reference Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology. 2004;127(5 Suppl 1):S17–26.PubMedCrossRef Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology. 2004;127(5 Suppl 1):S17–26.PubMedCrossRef
38.
go back to reference Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr. Relation of body mass index to cancer risk in 362, 552 Swedish men. Cancer Causes Control. 2006;17(7):901–9.PubMedCrossRef Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr. Relation of body mass index to cancer risk in 362, 552 Swedish men. Cancer Causes Control. 2006;17(7):901–9.PubMedCrossRef
39.
go back to reference Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N, Takahashi I, Chayama K. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2008;17(4):846–54.PubMedCrossRef Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N, Takahashi I, Chayama K. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2008;17(4):846–54.PubMedCrossRef
Metadata
Title
Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976–2005
Authors
Shan Gao
Wan-Shui Yang
Freddie Bray
Puthiery Va
Wei Zhang
Jing Gao
Yong-Bing Xiang
Publication date
01-01-2012
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 1/2012
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-011-9636-8

Other articles of this Issue 1/2012

European Journal of Epidemiology 1/2012 Go to the issue